.Merck trumps earnings expectations, raises purchases expectation on strong need for leading medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Estimates as Keytruda Sales Increase BloombergMerck Inventory: Pharma Giant Posts Solid End Results, But Overview Drops Short Capitalist's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck trumps income as well as purchases desires surrounded by Keytruda asset, however supplies combined full-year outlook MarketWatch.